Hydrogenology
Hydrogenology editorial study record

Hydrogen-generating Si-based agent protects against skin flap ischemia-reperfusion injury in rats.

Otani N, Tomita K, Kobayashi Y, Kuroda K, Koyama Y, Kobayashi H, Kubo T. · Scientific Reports. 2022;12:10228.

PreclinicalOther formsPublished 2022
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Controlled rat study

Research topic

Skin, wound and aging research

Administration classification

Other forms

Study result signal

Positive preclinical signal.

Outcome type

Animal tissue, perfusion and functional survival outcomes.

Reported in the source

Methods at a glance

Population or model

Adult male Sprague-Dawley rats in a skin-flap ischemia-reperfusion model.

Sample

24 rats; 8 each in sham, ischemia-reperfusion and supplemented ischemia-reperfusion groups.

Duration

One week of pretreatment, then 72 hours of reperfusion follow-up.

Intervention

AIN93M diet containing 1.0% silicon-based hydrogen-generating agent from one week before surgery.

Hydrogen form

Hydrogen generated in the gastrointestinal tract by a silicon-based dietary agent; not Brown's gas.

H₂ specification

A directly administered molecular-H2 dose was not measured.

H₂ flow

Not applicable — dietary agent.

O₂ delivered with H₂

No oxygen was co-delivered.

Comparator

Sham and ischemia-reperfusion groups on control diet.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Skin-flap survival, blood flow, histology and oxidative-stress measures.

Reported result

Flap survival was higher in supplemented rats than in ischemia-reperfusion controls, with favorable tissue and oxidative-stress measures.

Results-extraction completeness

The full article, methods, figures and measured outcomes were checked.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Animal evidence only; the silicon-based product is not equivalent to a clinical molecular-hydrogen intervention.

Applies directly to

The reported rat skin-flap model.

Preliminary appraisal framework

SYRCLE animal-study tool — preliminary

Preliminary risk-of-bias status

Some concerns

Appraisal rationale

Small groups and unclear allocation concealment and assessor blinding.

Appraisal domains

Randomization/allocation reporting is limited · Blinding of personnel is unclear · Attrition is incompletely reported in places · Blinding of outcome assessors is unclear · No prospectively registered analysis plan identified

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 35418596 · DOI: 10.1038/s41598-022-10228-6

Publisher access

Free full article in PubMed Central.

Extraction basis

PubMed record and PubMed Central full text; extraction checked 9 August 2026.

Record revision

2026-08-10